cepharanthine has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobuchi, H; Li, MJ; Matsuno, T; Utsumi, K; Yasuda, T | 1 |
1 other study(ies) available for cepharanthine and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
Inhibition of neutrophil priming and tyrosyl phosphorylation by cepharanthine, a nonsteroidal antiinflammatory drug.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Annexin A1; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Epidermal Growth Factor; Granulocyte Colony-Stimulating Factor; Humans; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Respiratory Burst; Tumor Necrosis Factor-alpha | 1992 |